CG Oncology (CGON) said Monday it closed a $238 million public offering of 9.2 million shares at $28 apiece.
The offering consists of 8.5 million shares sold by the company, inclusive of 1.2 million shares covered by the underwriters' option to purchase additional shares, and 700,000 shares sold by an existing shareholder, according to a statement.
CG Oncology said it did not receive any proceeds from the sale of shares by the selling stockholder.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.